No Longer Just Google-Backed, 23andMe Attracts $22M from J&J, Other Investors

Johnson & Johnson Development Corporation was among the investors in the company's $22 million Series C financing round.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.